JMP Group Announces Addition of Michael King as Equity Research Analyst

Before you go, we thought you'd like these...
Before you go close icon

JMP Group Announces Addition of Michael King as Equity Research Analyst

Managing Director to Broaden Firm's Coverage of the Biotechnology Sector

SAN FRANCISCO--(BUSINESS WIRE)-- JMP Group Inc. (NYSE: JMP), an investment banking and alternative asset management firm, announced today that Michael G. King, Jr. has joined JMP Securities as a senior equity research analyst. Mr. King, a managing director, follows the biotechnology industry. He is based in the firm's New York office.


"JMP Securities has one of the top life sciences franchises on Wall Street," said Mark Lehmann, president of JMP Securities. "Mike's arrival signifies JMP's dedication to further expanding that platform in order to provide ever greater value to the firm's institutional customers and corporate clients in this highly complex space. Mike is a seasoned analyst with a proven ability to generate differentiated perspectives and actionable insights as a result of a career that has included both accomplishments on the sell-side and successes within the biotech industry. He is a key addition in a key area for the firm."

Prior to joining JMP Securities, Mr. King was a managing director at Dawson James Securities, where he served as director of research and as a senior biotechnology analyst. He was previously a managing director and senior research analyst at Rodman & Renshaw, a senior vice president and director of corporate development at publicly traded ZIOPHARM Oncology, and a managing director and senior equity analyst at Wedbush Securities. Beforehand, Mr. King served as a managing director and senior biotechnology analyst both at Merriman Curhan Ford and at Rodman & Renshaw, where, in his initial tenure with the company, he was also the director of research. Additionally, Mr. King has held senior equity research positions at Banc of America Securities, Robertson Stephens, Vector Securities and Dillon Read & Co., covering a wide range of market capitalizations and therapeutic categories and earning recognition in analyst rankings produced by The Wall Street Journal and Institutional Investor. Mr. King began his career as a biotechnology specialist in the private client sales divisions of Alex. Brown & Co., Hambrecht & Quist and Kidder, Peabody & Co. He holds a BA in finance from The Bernard M. Baruch College of the City University of New York.

About JMP Group

JMP Group Inc. is a full-service investment banking and asset management firm that provides investment banking, sales and trading, and equity research services to corporate and institutional clients as well as alternative asset management products to institutional and high-net-worth investors. JMP Group operates through three subsidiaries: JMP Securities, Harvest Capital Strategies and JMP Credit Advisors. For more information, visit www.jmpg.com.

anImage


Investor Relations Contact:
JMP Group Inc.
Andrew Palmer, 415-835-8978
apalmer@jmpg.com
or
Media Relations Contact:
Dukas Public Relations
Seth Linden, 212-704-7385
seth@dukaspr.com
Zach Leibowitz, 212-704-7385
zach@dukaspr.com

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:

The article JMP Group Announces Addition of Michael King as Equity Research Analyst originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners